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Acute respiratory distress syndrome (ARDS) is the compli-
cation of many acute conditions, which can be characterised
with a non-cardiogenic lung edema and hypoxemia. The
most common risk factors for developing ARDS can be
grouped into direct (acute severe pneumonia, aspiration of
gastric content) and indirect (sepsis, acute severe pancreati-
tis, massive blood component transfusion) effects (Galvin et
al., 2011). The incidence of ARDS since 1990 has doubled
(Sigurdsson et al., 2013), and the level of mortality can
reach even 50% (Ferguson et al., 2007) in intensive care
unit (ICU) patients. The treatment of these patients can be
very complicated, and can include serious fluid manage-
ment, feeding, extra corporal membrane oxygenation, and
mechanical lung ventilation advanced techniques.
Imbalance between oxidants and antioxidants may play an
important role in pathogenesis of ARDS. The reactive oxy-
gen molecules can be produced by all cells in the organism
due to enzymatic and non-enzymatic processes. Lists of oxi-
dative stress markers associated with development of many
disorders are already known (Kumar et al., 2000; Bowler et
al., 2003; Crimi et al., 2006), but their predictive role in
ARDS is still underestimated. Reactive oxygen species ini-
tiate cellular tissue death by lipid peroxidation, and as a re-
sult also modulation of proteins and DNA.
Oxidative stress related molecules, such as malondialde-
chyde and 4-hydroxinonenal, are important products of
non-enzymatic reactions. On the other hand, protective
function is provided by antioxidative molecules, for exam-
ple, superoxiddismutase, glutathionperoxidase, and toco-
pherol.
The main aim of this study was to investigate the dynamic
changes of the level of oxidative stress markers in patients
with acute respiratory distress syndrome. The secondary
goal was to determine the relationship of the level of oxida-
tive stress markers to the outcome in patients with acute res-
piratory distress syndrome.
This prospective study was conducted in the ICU of Pauls
Stradiòð Clinical University hospital during six months in
2013 according to the following inclusion criteria: mechani-
cal lung ventilation 24 hours in patients over 18 years of age
and acute severe pneumonia, pancreatitis, sepsis or massive
blood component transfusion. The study was approved by
the Ethics Committee of Rîga Stradiòð University.
Patients with ARDS were monitored for seven days. The
ARDS was diagnosed according to the Berlin definition
(Ranieri et al., 2012) criteria, where: ARDS developed
within seven days due to direct or indirect cause, bilateral
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Acute respiratory distress syndrome is a common complication characterised by severe hypoxe-
mia, which leads to high mortality rates in ICU patients. Imbalance between oxidative stress
markers like oxidants and antioxidants may play an important role in pathophysiology of the syn-
drome. We observed 17 ARDS patients during seven days after inclusion, with the main goal to
describe dynamic changes in the level of oxidative stress markers in patients with acute respira-
tory distress syndrome. We found that there are dynamic differences in the level of malondialde-
chyde (MDA) and nitric oxide (NO) in patients with acute respiratory distress syndrome. There
were also different levels of oxidative stress markers in non-survivor compared with survivor
groups. Increased level of an oxidant like a thiobarbituric acid substance with malondialdechyde
(TBS_MDA) and antioxidant glutathionperoxidase (GPx) at the first day after inclusion was related
with poor outcome in patients with acute respiratory distress syndrome.
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opacities were obeserved on chest X-ray or CT scan and or-
igin of lung edema was not fully explained by cardiac fail-
ure or fluid overload. There are three stages of ARDS: 1)
mild — PaO2/FiO2 200–300 with PEEP or CPAP  5
cmH2O, 2) moderate — PaO2/FiO2 101–199 with PEEP 
5 cmH2O, and severe — PaO2/FiO2 100 with PEEP  5
cmH2O. Blood samples were taken on the 1st and 4th day
after inclusion
Oxidative stress biomarkers — MDA (malondialde-
chyde), TBS (thiobarbituric acid reactive substance), 4-
HNE (4-hydroxinonenal), and NO (nitric oxide) — were de-
termined spectrophotometrically using a Microplate reader
Infinity 2000 (Tecan Ltd.).
The assay of MDA, 4-HNE is based on the reaction of a
chromogenic reagent, N-methyl-2-phenylindole with MDA
and 4-hydroxyalkenals at 45 °C. One molecule of either
MDA or 4-hydroxyalkenal reacts with two molecules of
reagent R1 to yield a stable chromophore with maximal ab-
sorbance at 586 nm (Esterbauer et al., 1990; Janero, et al.,
1990).
The Thiobarbituric Acid Reactive Substances (TBARS) As-
say Kit is a tool for the direct quantitative measurement of
MDA in biological samples. Unknown MDA containing
samples or MDA standards were first reacted with TBA at
95 °C. After a brief incubation, the samples and standards
were read spectrophotometrically. The MDA content in un-
known samples was determined by comparison with a pre-
determined MDA standard curve (Armstrong et al., 1994;
1998).
Antioxidative biomarkers — tocopherol, SOD (superoxid-
dismutase), and GPx (glutathionperoxidase) — were deter-
mined spectrophotometrically using a clinical biochemistry
analyser RX Daytona (Randox lab., Ltd).
The method of GPx determination was based on catalysa-
tion of oxidation of glutathione by cumene hydroperoxide.
In the presence of glutathione reductase and NADPH the
oxidised glutathione is converted to a reduced form.
To determine SOD we used heparinised whole blood sam-
ples, which were centrifuged at 3000 rpm 10 minutes fol-
lowed by aspiration of the plasma. Erythrocytes were then
washed three times with isotonic saline solution with centri-
fuging for 10 minutes at 3000 rpm after each wash. The so-
lution of washed centrifuged erythrocytes (0.2 ml) was then
made up to 2.0 ml with cold redistilled water, mixed and
left to stand at +4 °C for 15 minutes. Xanthine and xanthine
oxidase were used to generate superoxide radicals that react
with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetra-
zolium chloride. The superoxide dismutase activity was
then measured by the degree of inhibition of this reaction.
Clinical and laboratory parameters were collected according
to the study protocol.
Medians and interquartile ranges (IQR) were calculated for
biomarker serum levels. The Wilcoxon Signed Rank Test
was used for testing significant differences of dependent
events and the Mann–Whitney U Test for respective inde-
pendent events. Statistically significance was assumed p <
0.05. Statistical calculations were performed using the
SPSS 21.0 programme.
Forty patients were observed, including 17 ARDS patients
with acute severe pneumonia, pancreatitis, sepsis and differ-
ent stages of ARDS according to the Berlin definition and
inclusion criteria.
Oxidants. Statistically significant dynamic changes were
shown for MDA, from median value of 2[2-3] µM in the 1st
day and 2[1-2] µM on the 4th day (p = 0.05, Wilcoxon
Signed Rank Test).
Level of the biomarker nitric oxide decreased from
22.7[15.3-43.7] µM on the 1st day to 20.0[9.9-39.9] µM on
the 4th day, but this change was not significantly different
(p = 0.062, Wilcoxon Signed Rank Test).
Among antioxidants, GPx, the most important biomarker
investigated, significantly decreased from 4749[4026-5568]
U/L on the 1st day to 4034[3797-4784] U/L on the 4th day
(p = 0.03, Wilcoxon Signed Rank Test) (Table 1).
Six patients of 17 included suffered mortality. Deceased pa-
tients had twice higher level of the oxidant TBS_MDA
(9.5[8.0-10.0] µM) at the 1st day if compare with survivors,
where the level of TBS_MDA was 4.0[3.0-6.0] mkM (p =
0.035, Mann–Whitney U Test). On the other hand the activ-
ity of antioxidant GPx at the 1st day was higher in non-
survivors 5179[4638-6365] µM if compare with survivors
4585[3728-5023] µM (p = 0.019, Mann–Whitney U Test)
(Table 2).
The results of our study shows a relationed between in-
creased level of TBS_MDA and activity of GPx and poor
outcome in ARDS patients, likely via cellular oxidative
stress related tissue damage. In critically ill patients ARDS
develops into multi-organ dysfunction and inflammation.
Due to this, oxidative stress in ARDS patients can be a sec-
ondary reason for outcome. Our study shows changes in
levels of biomarkers of oxidative stress, especially on the
T a b l e 1
DYNAMIC CHANGES OF OXIDATIVE STRESS MARKERS






MDA, mkM 2[2-3] 2[1-2] 0.05
4-HNE, mkM 3[2-4] 3[1-3] 0.69
NO, mkM 23[15-44] 20[10-40] 0.06
MDA+4-HNE 5[4-6] 4[3-5] 0.39
TBS_MDA 6[4-8] 5[4-6] 0.53
Antioxidants
GPx, U/L 4749[4026-5568] 4034[3797-4784] 0.03
SOD, U/gHb 1627[1386-1697] 1527[1352-1692] 0.21
1 Wilcoxon Signed Rank Test
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1st day after inclusion, which suggests that they play an im-
portant role in pathophysiology of ARDS.
According to recent studies, oxidative stress is an important
process also in patients with hepatic malfunction, where
lipid peroxidation is the main mechanism (Lichtenstern et
al., 2011). Antioxidants showed greater activity in septic
patients, which is in contrast with the results of our study
and may be explained by different changes in levels of anti-
oxidants for various diseases (Alonso de Vega et al.,
2002).
Based on the results of our study we concluded that there
are dynamic differences in the level of oxidants and antioxi-
dants in patients with acute respiratory distress syndrome.
Increased levels of the oxidant TBS_MDA and antioxidant
GPx on the first day after inclusion was related with poor
outcome in patients with acute respiratory distress syn-
drome.
Due to the fact that ARDS is still underdiagnosed and is as-
sociated with high mortality rate, it is important to study the
pathogenesis of the syndrome in the Latvian population.
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T a b l e 2
RELATION OF THE LEVEL OF OXIDATIVE STRESS MARKERS
WITH OUTCOME IN ARDS PATIENTS
Biomarker
Non survivors (n = 6) Survivors (n = 11)
Median value
[IQR] 1st day




4-HNE, mkM 3[2-4] 0,94 4[1-4] 0.94
NO, mkM 33[15-72] 0,31 23[12-40] 0.31
TBS_MDA 10[8-10] 0,03 4[3-6] 0.03
Antioxidants
GPx, U/L 5179[4638-6365] 0,02 4585[3728-5023] 0.02
SOD, U/gHb 1641[1384-1697] 0,89 1470[1386-1725] 0.89
1 Mann–Whitney U Test
OKSIDATÎVÂ STRESA MARÍIERU AKTIVITÂTE AKÛTA RESPIRATORA DISTRESA SINDROMA GADÎJUMÂ
Akûts respirators distresa sindroms (ARDS) ir viena no bieþâkajâm komplikâcijâm, kas saistîta ar smagu hipoksçmiju un augstu mirstîbu
intensîvâs terapijas un reanimâcijas nodaïas pacientu vidû. Lîdzsvara traucçjumi starp oksidantiem un antioksidantiem var nopietni ietekmçt
ARDS patofizioloìiju. Dinamikâ tika novçroti 17 pacienti ar ARDS septiòu dienu laikâ kopð iekïauðanas pçtîjumâ ar mçríi sekot izmaiòâm
oksidantu un antioksidantu aktivitâtç. Saskaòâ ar iegûtajiem rezultâtiem tika secinâts, ka pacientiem ar ARDS dinamiski izmainâs tâdu
oksidantu aktivitâte kâ malondialdehîds un slâpekïa oksîds. Miruðo pacientu grupâ oksidantu un antioksidantu lîmenis bija atðíirîgs
salîdzinâjumâ ar izdzîvojuðiem pacientiem. Paaugstinâta tiobarbitûrskâbes atvasinâjumu un glutationperoksidâzes aktivitâte pirmajâ dienâ
kopð iekïauðanas pçtîjumâ pozitîvi korelç ar nelabvçlîgu slimîbas iznâkumu pacientiem ar akûtu respiratoru distresa sindromu.
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